Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the ...

For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.

In FY25, India's pharmaceutical exports reached a record high, surpassing $30 billion (approximately $30.47 billion), a ...

The pharmaceutical sector on both sides of the Atlantic appeared to have dodged Trump’s tariffs last night, as pharmaceutical products were among several categories exempted from reciprocal tariffs, ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic, according ...

A parliamentary panel’s recent criticism of India’s drug price control mechanism has kept industry circles buzzing as the ...

Pharma sector–linked buyers snapped up properties worth over ₹1,530 crore in 2025, signalling the rising flow of pharmaceutical wealth into real estate | Real Estate News ...